Literature DB >> 35363877

Active smokers are at higher risk of COVID-19 death: A systematic review and meta-analysis.

Roengrudee Patanavanich1, Tanatorn Siripoon1, Salin Amponnavarat1, Stanton A Glantz2.   

Abstract

INTRODUCTION: Current evidence indicates that smoking worsens COVID-19 outcomes. However, when studies restricted their analyses to current smokers, the risks for COVID-19 severity and death are inconsistent. This meta-analysis explored the association between current smoking and the risk for mortality based on the studies that reported all three categories of smoking (current, former, and never smokers) to overcome the limitation of the previous meta-analyses which former smokers might have been classified as non-smokers.
METHODS: We searched PubMed and Embase up to 1 January 2021. We included studies reporting all three categories of smoking behaviors of COVID-19 patients and mortality outcomes. A random-effects meta-analysis and meta-regression were used to examine relationships in the data.
RESULTS: A total of 34 articles with 35,193 COVID-19 patients was included. The meta-analysis confirmed the association between current smoking (OR 1.26, 95% CI: 1.01-1.58) and former smoking (OR 1.76, 95% CI: 1.53-2.03) with COVID-19 mortality. We also found that the risk for COVID-19 death in current smokers does not vary by age, but significantly drops by age in former smokers. Moreover, current smokers in non-high-income countries have higher risks of COVID-19 death compared with high-income countries (OR 3.11, 95% CI: 2.04-4.72 vs. OR 1.14, 95% CI: 0.91-1.43; p=0.015).
CONCLUSIONS: Current and former smokers are at higher risk of dying from COVID-19. Tobacco control should be strengthened to encourage current smokers to quit and prevent the initiation of smoking. Public health professionals should take the COVID-19 pandemic as an opportunity to promote smoking prevention and cession. IMPLICATIONS: This study makes an important contribution to the existing literature by distinguishing between current and former smoking and their separate effects on COVID-19 mortality. We also explore the effects by age of patients and country income level. Findings from this study provide empirical evidence against misinformation about the relationship between smoking and COVID-19 mortality.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2022        PMID: 35363877     DOI: 10.1093/ntr/ntac085

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  2 in total

1.  Commentary: Smoking, nicotine and COVID-19 outcomes: unprecedented challenges to epidemiologists.

Authors:  Tai Hing Lam
Journal:  Int J Epidemiol       Date:  2022-08-10       Impact factor: 9.685

2.  Cigarette Smoking in Response to COVID-19: Examining Co-Morbid Medical Conditions and Risk Perceptions.

Authors:  Lisa M Fucito; Krysten W Bold; Sydney Cannon; Alison Serrantino; Rebecca Marrero; Stephanie S O'Malley
Journal:  Int J Environ Res Public Health       Date:  2022-07-06       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.